Liver Cancer Clinical Trials in Los Angeles, California

4 studies are recruiting for liver cancer in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

   AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various dose levels in an all-comers advanced solid cancer patient population. AGX101will be administered intravenously. Dosing of AGX101 will be re…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   USC/Norris Comprehensive Cancer Center, Los Angeles, California

   Locations

   7 in total

   Run by

   Angiex, Inc.

   See if you can join NCT06440005 on ClinicalTrials.gov

2. National Liver Cancer Screening Trial

   The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or patients with chronic hepatitis B infection. Eligible patients will be randomized in a 1:1 fashion to A…

   Stage

   Phase 4

   Ages

   18 to 85

   Site

   University of Southern California, Los Angeles, California

   Locations

   19 in total

   Run by

   University of Texas Southwestern Medical Center

   See if you can join NCT06084234 on ClinicalTrials.gov

3. ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

   Open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety/tolerability and determine the recommended Phase II Dose (RP2D) of ET140203 T-cells in pediatric subjects who are AFP-positive/HLA-A2-positive and have relapsed/refractory HB, HCN-NOS, or HCC.

   Stage

   Phase 1

   Ages

   1 to 21

   Site

   Children's Hospital Los Angeles, Los Angeles, California

   Locations

   4 in total

   Run by

   Eureka Therapeutics Inc.

   See if you can join NCT04634357 on ClinicalTrials.gov

4. Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

   Patients with digestive tract malignancy often experience severe and unremitting abdominal pain that negatively affects physical, emotional, and social function, as well as health related quality of life (HRQOL). Therapeutic virtual reality (VR) has emerged as a promising and evidence-based treatme…

   Stage

   Not phased

   Ages

   18 to 99

   Site

   Cedars-Sinai Medical Center, Los Angeles, California

   Run by

   Cedars-Sinai Medical Center

   See if you can join NCT04907643 on ClinicalTrials.gov